Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
I led the FDA’s food safety and nutrition center. Here’s what people are missing about the cyclospora outbreak
1+ day, 10+ hour ago (285+ words) Mayne served as director of the FDA’s Center for Food Safety and Applied Nutrition from 2015-2023. I spent nearly a decade leading FDA’s Center for Food Safety and Applied Nutrition. That role convinced me that food safety and nutrition are interdependent…...
FDA advisory panel narrowly rejects compounding of one peptide, backs two others
1+ day, 10+ hour ago (648+ words) By Lizzy Lawrence and Sarah Todd WASHINGTON — A Food and Drug Administration advisory panel recommended on Friday that compounding pharmacies be allowed to manufacture the peptides epitalon and semax, but narrowly voted to recommend against manufacturing emideltide. The two-day meeting…...
There are already more U.S. measles cases this year than in all of 2025
1+ day, 14+ hour ago (784+ words) The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months of 2026 still to come. The U.S. Centers for Disease Control and Prevention logged 2,318 cases of measles as of Thursday, according to an…...
Up and down the ladder: The latest comings and goings
1+ day, 14+ hour ago (202+ words) STAT is a media company focused on finding and telling compelling stories about health, medicine, and scientific discovery. We produce daily news, investigative articles, and narrative projects in addition to multimedia features, podcasts, and opinion pieces. We tell our stories…...
Pharmalittle: We're reading about an FDA panel and peptides, a Merck license for an HIV pill, and more
1+ day, 17+ hour ago (350+ words) STAT Pharmalittle: We’re reading about an FDA panel and peptides, a Merck license for an HIV pill, and more People with diabetes are having trouble finding a Sanofi long-acting insulin pen Pharmalot Columnist, Senior Writer Ed’s stories explore prescription drug…...
Fatal gene-editing trial in China raises ethics and oversight questions
1+ day, 16+ hour ago (171+ words) Meghana Keshavan is a biotech correspondent at STAT and co-writer of The Readout newsletter. She joined STAT in 2016. She has written about the life sciences industry for more than a decade. Before that, she worked for news outlets like Thomson…...
Merck strikes voluntary licensing deals in poor countries for an experimental HIV prevention pill
1+ day, 19+ hour ago (200+ words) STAT Amid rising concern over efforts to contain HIV, Merck has reached voluntary licensing deals with seven companies to make generic versions of an experimental, once-a-month prevention pill in 129 low- and middle-income countries. The agreements will allow the manufacturers — three…...
The U.S. pharmaceutical supply chain problem is not about China
1+ day, 22+ hour ago (423+ words) Yerramilli is a clinical assistant professor at NYU Grossman School of Medicine and Council on Foreign Relations term member. In 2025, there were 216 active drug shortages in the U.S., impacting Americans’ access to lifesaving medications. The resilience of our pharmaceuticals supply chains…...
I may be one of the last middle-class medical students who could afford to become a doctor
1+ day, 22+ hour ago (521+ words) Gurumurthy is a third-year medical student. Every so often, I catch myself wondering, what if I had applied to medical school just two years later? As another class of medical students matriculates, that question has become harder to ignore. On…...
White House offers its science blueprint: More AI, less life sciences
1+ day, 22+ hour ago (264+ words) Anil Oza is a general assignment reporter at STAT. He was formerly the 2024-2025 Sharon Begley Science Reporting Fellow and a spring 2023 "Color Code" intern. He previously covered all things science, from grassroots efforts to study the effect of urban heat…...